Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies

BACKGROUND: The United States (US) Food and Drug Administration (FDA) is responsible for the protection of the public health by assuring the safety, effectiveness and security of human drugs and biological products through the enforcement of the Federal Food, Drug and Cosmetic Act (FDCA) and related...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Diane, Seoane-Vazquez, Enrique, Rodriguez-Monguio, Rosa, Montagne, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582490/
https://www.ncbi.nlm.nih.gov/pubmed/23339419
http://dx.doi.org/10.1186/1472-6963-13-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582490/
https://www.ncbi.nlm.nih.gov/pubmed/23339419
http://dx.doi.org/10.1186/1472-6963-13-27

Ejemplares similares